20102019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Valeria Piazzolla is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 27 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

Boni, C., Janssen, H. L. A., Rossi, M., Yoon, S. K., Vecchi, A., Barili, V., Yoshida, E. M., Trinh, H., Rodell, T. C., Laccabue, D., Alfieri, A., Brillo, F., Fisicaro, P., Acerbi, G., Pedrazzi, G., Andreone, P., Cursaro, C., Margotti, M., Santoro, R., Piazzolla, V. & 15 others, Brunetto, M. R., Coco, B., Cavallone, D., Zhao, Y., Joshi, A., Woo, J., Lau, A. H., Gaggar, A., Subramanian, G. M., Massetto, B., Fung, S., Ahn, S. H., Ma, X., Mangia, A. & Ferrari, C., Jul 1 2019, In : Gastroenterology. 157, 1, p. 227-241.e7

Research output: Contribution to journalArticle

  • Performance of three common hepatitis c virus (HCV) genotyping assays for identification of HCV genotype 2/1 chimeras

    Peiffer, K. H., Kuhnhenn, L., Stelzl, E., Dietz, J., Susser, S., Tal, A. O., Finkelmeier, F., Zuckerman, E., Cornberg, M., Barak, M., Piazzolla, V., Mangia, A., Zeuzem, S., Kessler, H. H., Vermehren, J. & Sarrazin, C., Jan 1 2019, In : Journal of Clinical Microbiology. 57, 7, e00060-19.

    Research output: Contribution to journalArticle

  • SVR12 Higher than 97% in GT3 Cirrhotic Patients with Evidence of Portal Hypertension Treated with SOF/VEL without Ribavirin: A Nation-Wide Cohort Study

    Mangia, A., Cenderello, G., Copetti, M., Verucchi, G., Piazzolla, V., Lorusso, C., Santoro, R., Squillante, M. M., Orlandini, A., Minisini, R. & Ciancio, A., Apr 4 2019, In : Cells. 8, 4

    Research output: Contribution to journalArticle

  • SVR12 rates higher than 99% after sofosbuvir/ velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience

    Mangia, A., Piazzolla, V., Giannelli, A., Visaggi, E., Minerva, N., Palmieri, V., Carraturo, I., Potenza, D., Napoli, N., Lauletta, G., Tagarielli, V., Santoro, R., Piccigallo, E., De Gioia, S., Chimenti, A., Cuccorese, G., Metrangolo, A., Mazzola, M., Agostinacchio, E., Mennea, G. & 4 others, Sabbà, C., Cela, M., Copetti, M. & Losappio, R., May 1 2019, In : PLoS One. 14, 5, e0215783.

    Research output: Contribution to journalArticle

    Open Access
  • TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues

    Boni, C., Vecchi, A., Rossi, M., Laccabue, D., Giuberti, T., Alfieri, A., Lampertico, P., Grossi, G., Facchetti, F., Brunetto, M. R., Coco, B., Cavallone, D., Mangia, A., Santoro, R., Piazzolla, V., Lau, A., Gaggar, A., Subramanian, G. M. & Ferrari, C., May 1 2018, In : Gastroenterology. 154, 6, p. 1764-1777.e7

    Research output: Contribution to journalArticle